ArticleJournal of medicinal chemistry2025

RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors.

Gurushankar Chandramouly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.